Home Halogens 3,5-Dibromo-L-tyrosine

3,5-Dibromo-L-tyrosine

CAS No.:
300-38-9
Catalog Number:
AG003IL6
Molecular Formula:
C9H9Br2NO3
Molecular Weight:
338.9807
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
≥ 98% (HPLC)
1 week
United States
$67
- +
25g
≥ 98% (HPLC)
1 week
United States
$140
- +
100g
≥ 98% (HPLC)
1 week
United States
$403
- +
250g
≥ 98% (HPLC)
1 week
United States
$857
- +
Product Description
Catalog Number:
AG003IL6
Chemical Name:
3,5-Dibromo-L-tyrosine
CAS Number:
300-38-9
Molecular Formula:
C9H9Br2NO3
Molecular Weight:
338.9807
MDL Number:
MFCD00037204
IUPAC Name:
(2S)-2-amino-3-(3,5-dibromo-4-hydroxyphenyl)propanoic acid
InChI:
InChI=1S/C9H9Br2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1
InChI Key:
COESHZUDRKCEPA-ZETCQYMHSA-N
SMILES:
OC(=O)[C@H](Cc1cc(Br)c(c(c1)Br)O)N
EC Number:
206-091-5
UNII:
QD49LEP46E
Properties
Complexity:
227  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
338.893g/mol
Formal Charge:
0
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
338.983g/mol
Monoisotopic Mass:
336.895g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
83.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4  
Literature
Title Journal
Brominated tyrosine and polyelectrolyte multilayer analysis by laser desorption vacuum ultraviolet postionization and secondary ion mass spectrometry. Analytical chemistry 20110615
Halogenated aromatic amino acid 3,5-dibromo-D: -tyrosine produces beneficial effects in experimental stroke and seizures. Amino acids 20110401
Identification of dihalogenated proteins in rat intestinal mucosa injured by indomethacin. Journal of clinical biochemistry and nutrition 20110301
Brominated compounds from marine sponges of the genus Aplysina and a compilation of their 13C NMR spectral data. Marine drugs 20110101
Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20091001
Marine-derived metabolites of S-adenosylmethionine as templates for new anti-infectives. Marine drugs 20090901
Quantification of Modified Tyrosines in Healthy and Diabetic Human Urine using Liquid Chromatography/Tandem Mass Spectrometry. Journal of clinical biochemistry and nutrition 20090101
Preparation and Characterization of a Polyclonal Antibody against Brominated Protein. Journal of clinical biochemistry and nutrition 20090101
Halogenated derivatives of aromatic amino acids exhibit balanced antiglutamatergic actions: potential applications for the treatment of neurological and neuropsychiatric disorders. Recent patents on CNS drug discovery 20061101
Bromine is an endogenous component of a vanadium bromoperoxidase. Journal of the American Chemical Society 20051109
Sputum analysis in diagnosis and management of obstructive airway diseases. Therapeutics and clinical risk management 20050901
Immunogenicity of a brominated protein and successive establishment of a monoclonal antibody to dihalogenated tyrosine. Free radical biology & medicine 20050101
NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis. Magnetic resonance in medicine 20041001
Neuroprotective action of halogenated derivatives of L-phenylalanine. Stroke 20040501
Self-association of model transmembrane alpha-helices is modulated by lipid structure. Biochemistry 20011016
Properties